conduct
prospect
pilot
studi
period
new
caledonia
prepar
pneumonia
research
child
health
perch
project
pathogen
associ
hospit
lower
respiratori
infect
children
identifi
use
cultur
induc
sputum
blood
urinari
antigen
detect
polymeras
chain
reaction
pcr
respiratori
specimen
serolog
pair
sera
respiratori
virus
detect
respiratori
specimen
immunofluoresc
pcr
serolog
pair
sera
pathogen
detect
hospit
case
virus
repres
pathogen
detect
respiratori
syncyti
viru
rhinoviru
frequent
account
pathogen
identifi
respect
induc
sputum
specimen
collect
determin
good
qualiti
may
consequ
collect
method
use
accord
world
health
organ
estim
infecti
diseas
especi
pneumonia
lead
caus
death
global
children
younger
year
age
accur
rapid
diagnosi
etiolog
lower
respiratori
infect
lri
challeng
especi
children
uptod
lri
epidemiolog
data
therefor
essenti
determin
first
line
antibiot
therapi
use
countri
identifi
potenti
new
pathogen
target
futur
vaccin
goal
pneumonia
etiolog
research
child
health
perch
project
order
gather
data
design
perch
studi
pilot
studi
undertaken
new
caledonia
littl
known
respiratori
pathogen
respons
lri
new
caledonia
chest
physiotherapi
recommend
infant
bronchiol
standard
care
also
often
use
patient
difficulti
breath
due
pneumonia
besid
therapeut
procedur
chest
physiotherapi
also
use
obtain
induc
sputum
specimen
recent
establish
induc
sputum
analysi
could
relev
diagnosi
communityacquir
pneumonia
children
key
specimen
collect
perch
pilot
site
perch
project
object
studi
evalu
relev
induc
sputum
etiolog
diagnosi
lri
children
ii
evalu
relev
nasopharyng
specimen
collect
case
compar
specimen
collect
control
new
caledonia
french
archipelago
locat
south
pacif
popul
inhabit
censu
one
quarter
popul
year
old
ethnic
distribut
within
age
group
follow
melanesian
european
polynesian
peopl
mix
ethnic
indonesian
ethnic
group
multicultur
popul
mainli
urban
rural
lifestyl
live
tribal
villag
new
caledonia
two
mark
season
warm
wet
season
decembermarch
cooler
one
juneseptemb
popul
excel
access
health
care
system
possess
european
standard
howev
medic
consult
sometim
delay
peopl
live
tribal
villag
andor
use
tradit
medicin
first
point
care
casecontrol
studi
conduct
new
caledonia
hospit
noumea
januari
januari
case
popul
hospit
children
year
admit
lri
ie
pneumonia
bronchiol
enrol
prospect
criteria
describ
tabl
use
patient
enrol
lri
classifi
sever
sever
use
criteria
children
year
consult
hospit
emerg
depart
admiss
hospit
appoint
outpati
ward
without
respiratori
symptom
check
match
elig
case
tabl
sign
written
inform
parent
consent
obtain
enrol
data
specimen
collect
upon
enrol
standard
questionnair
use
record
demograph
epidemiolog
data
clinic
radiolog
featur
medic
histori
case
control
case
assess
hour
hospit
discharg
followup
senior
radiologist
review
chestxray
confirm
specimen
collect
shortli
admiss
case
two
differ
respiratori
tract
specimen
collect
nasopharyng
specimen
np
consist
nasopharyng
aspir
npa
nasopharyng
flock
swab
npf
parent
children
refus
npa
ii
induc
sputum
induc
sputum
collect
chest
physiotherapist
clear
upper
airway
use
increas
exhal
techniqu
iet
clear
distal
airway
assist
cough
ac
facilit
largeairway
clearanc
manual
compress
infant
thorax
use
iet
aim
achiev
distal
airway
flow
limit
low
lung
volum
facilit
mucu
clearanc
npa
induc
sputum
specimen
divid
part
one
steril
vial
bacteri
cultur
one
viral
transport
medium
vtm
viru
detect
npf
copan
diagnost
place
stgg
skim
milktrypton
glucoseglycerol
medium
vtm
blood
collect
cultur
serolog
acut
serum
convalesc
serum
week
admiss
antibacteri
activ
detect
procalcitonin
measur
urin
collect
urinari
antigen
detect
control
one
respiratori
sampl
npa
npf
parent
children
refus
npa
collect
process
describ
acut
convalesc
sera
also
collect
test
perform
institut
pasteur
new
caledonia
noumea
new
caledonia
except
serolog
test
detect
virus
chlamydophila
pneumonia
perform
canterburi
health
laboratori
christchurch
new
zealand
microbiolog
test
carri
respiratori
specimen
accord
french
societi
microbiolog
sfm
criteria
induc
sputum
sampl
gram
stain
leukocyt
epitheli
cell
count
record
good
qualiti
induc
sputum
granulocyt
epitheli
cell
per
low
power
field
retain
cultur
induc
sputum
npa
specimen
digest
ad
dithiothreitol
digesteur
eurobio
equal
amount
sampl
volum
cultur
blood
agar
nalidix
acid
chocol
agar
induc
sputum
cultur
count
result
express
colonyform
unit
per
millilitr
cfuml
interpret
use
sfm
standard
npf
gram
stain
cultur
agar
media
induc
sputum
npa
blood
cultur
use
bactalert
system
pediatr
bottl
legionella
pneumophila
serogroup
antigen
detect
nonconcentr
urin
use
immunochromatograph
assay
binax
binax
inc
digest
sampl
obtain
induc
sputum
npa
vtm
obtain
npf
centrifug
epitheli
cell
spot
onto
multiwel
microscop
slide
fix
stain
use
monofluo
kit
biorad
detect
influenza
b
virus
parainfluenza
viru
type
adenoviru
adv
cell
also
subject
monofluo
screen
biorad
respiratori
syncyti
viru
rsv
detect
nucleic
acid
extract
molecular
analysi
induc
sputum
np
rna
dna
contain
induc
sputum
np
extract
vtm
easymag
system
realtim
pcr
perform
induc
sputum
np
parallel
detect
chlamydophila
pneumonia
mycoplasma
pneumonia
detect
bordetella
pertussi
previous
describ
use
lightcycl
realtim
pcr
system
roch
diagnost
detect
procedur
perform
induc
sputum
np
use
previous
publish
multiplex
rtpcr
protocol
slight
modif
serolog
particl
agglutin
serodia
mycoii
fujirebio
perform
detect
immunoglobulin
igm
antibodi
mycoplasma
pneumonia
use
elisa
immunoassay
euroimmun
detect
antibodi
influenza
b
virus
adv
rsv
immunofluoresc
mrl
diagnost
cypress
detect
antibodi
c
pneumonia
detect
prehospit
antibiot
use
acut
serum
screen
antibacteri
activ
detect
prehospit
antibiot
use
describ
elsewher
procalcitonin
measur
procalcitonin
level
measur
use
vida
brahm
pct
assay
case
popul
viral
infect
confirm
one
condit
presenc
respiratori
viru
detect
induc
sputum
andor
np
immunofluoresc
realtim
pcr
multiplex
rtpcr
ii
seroconvers
greater
rise
reciproc
antibodi
titer
respiratori
viru
pair
serum
sampl
bacteri
infect
confirm
one
condit
presenc
usual
respiratori
pathogen
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
moraxella
catarrhali
cultur
blood
ii
presenc
usual
respiratori
pathogen
cultur
good
qualiti
induc
sputum
iii
urinari
antigen
test
posit
l
pneumophila
iv
pcr
induc
sputum
np
posit
pneumonia
c
pneumonia
b
pertussi
v
presenc
igm
reciproc
antibodi
titer
pneumonia
acut
andor
convalesc
serum
vi
seroconvers
greater
rise
reciproc
antibodi
titer
c
pneumonia
control
popul
infect
confirm
one
condit
presenc
usual
respiratori
pathogen
detect
np
cultur
immunofluoresc
pcr
multiplex
rtpcr
ii
seroconvers
greater
rise
reciproc
antibodi
titer
respiratori
virus
observ
pair
serum
sampl
iii
presenc
igm
reciproc
antibodi
titer
pneumonia
acut
convalesc
serum
iv
seroconvers
greater
rise
reciproc
antibodi
titer
c
pneumonia
calcul
median
interquartil
rang
iqr
continu
variabl
absolut
number
proport
categor
variabl
comparison
group
conduct
use
student
test
wilcoxon
ranksum
test
continu
variabl
chisquar
fisher
exact
test
categor
variabl
appropri
report
p
valu
p
consid
signific
simpl
kappa
coeffici
calcul
assess
agreement
induc
sputum
nasopharyng
sampl
statist
analys
perform
use
stata
statacorp
lp
colleg
station
children
hospit
lri
studi
period
enrol
studi
bronchiol
pneumonia
other
screen
elig
studi
refus
consent
patient
characterist
summar
tabl
patient
sever
lri
pneumonia
bronchiol
younger
p
like
live
tribal
villag
n
vs
n
p
melanesian
patient
overrepres
studi
compar
gener
popul
new
caledonia
vs
p
signific
associ
ethnic
group
lri
sever
none
patient
die
induc
sputum
obtain
case
also
np
collect
twenti
six
induc
sputum
sampl
good
qualiti
match
np
patient
test
presenc
antibiot
bodi
hospit
admitt
case
antibacteri
activ
found
sera
case
enrol
pathogen
detect
figur
yield
higher
case
bronchiol
pneumonia
vs
p
viral
pathogen
found
case
bacteri
pathogen
identifi
monomicrobi
infect
polymicrobi
infect
tabl
bacteria
detect
cultur
blood
cultur
test
posit
catarrhali
cultur
goodqual
induc
sputum
sampl
test
posit
variou
bacteria
detect
serolog
pcr
urinari
sampl
test
posit
l
pneumophila
serogroup
virus
detect
immunofluoresc
pcr
serolog
pathogen
virus
bacteria
detect
induc
sputum
sampl
pcr
season
distribut
two
frequent
detect
virus
rsv
hrhv
shown
figur
incid
lri
especi
bronchiol
higher
march
june
associ
season
distribut
rsv
four
influenza
virus
detect
southern
winter
august
septemb
case
aim
enrol
one
control
match
age
date
admiss
control
enrol
prove
challeng
due
difficulti
obtain
inform
consent
children
without
lri
novelti
conduct
research
pediatr
depart
twentytwo
control
enrol
least
one
pathogen
detect
bacteria
detect
control
virus
bacteria
virus
cultur
np
yield
bacteria
control
detect
virus
control
pcr
serolog
pcr
immunofluoresc
commonli
found
virus
rsv
hrhv
agreement
induc
sputum
np
sampl
high
kappa
tabl
number
small
reliabl
determin
agreement
virus
detect
agreement
viru
detect
high
kappa
bacteria
agreement
sampl
lower
induc
sputum
compar
regardless
qualiti
kappa
bacteri
pathogen
also
subset
pair
consist
goodqual
induc
sputum
sampl
kappa
compar
studi
first
descript
pathogen
associ
lri
hospit
children
new
caledonia
case
pathogen
detect
consist
publish
result
set
mostli
due
elev
number
viral
pathogen
detect
case
evid
viral
infect
bacteria
repres
pathogen
detect
howev
use
pcr
detect
classic
bacteria
low
bacteri
detect
could
consequ
use
less
sensit
test
may
also
result
fact
case
enrol
clinic
diagnosi
bronchiol
like
viral
origin
studi
produc
four
main
find
regard
lri
viral
origin
children
new
caledonia
first
molecular
tool
enabl
us
detect
newer
virus
includ
hmpv
hcov
hbov
previous
describ
respiratori
infect
never
identifi
set
second
rsv
infect
clearli
season
peak
begin
cool
season
like
promot
commun
life
begin
school
year
third
season
distribut
influenza
children
appear
concord
previou
find
adult
major
case
occur
june
septemb
howev
abil
assess
flu
season
limit
total
number
influenza
case
observ
studi
period
surprisingli
small
associ
viral
type
b
c
none
case
accompani
pneumococc
superinfect
differ
descript
absenc
infect
may
due
small
number
find
import
emphas
valu
longterm
continu
surveil
monitor
trend
influenza
respiratori
virus
time
final
hrhv
detect
throughout
year
common
case
control
call
question
role
lri
pathogen
like
miss
detect
mani
bacteri
pathogen
due
sever
import
factor
first
small
minor
pneumonia
case
bacterem
even
absenc
prior
antibiot
second
obtain
goodqual
induc
sputum
specimen
appropri
microbiolog
investig
despit
studi
emphasi
collect
specimen
third
culturebas
method
affect
prior
antibiot
administr
patient
evid
antibiot
use
hospit
admiss
studi
yield
induc
sputum
high
previous
describ
obtain
specimen
case
lri
one
quarter
sampl
children
pneumonia
good
qualiti
compar
good
qualiti
sampl
studi
finland
kilifi
kenya
perch
pilot
studi
differ
method
use
sputum
induct
iet
vs
hyperton
salin
nebul
techniqu
frequent
turnov
physiotherapist
studi
like
least
partial
respons
discrep
observ
studi
perch
studi
sputum
collect
hyperton
salin
nebul
method
use
kenyan
pilot
studi
train
specimen
collect
standard
across
site
effort
obtain
qualiti
specimen
children
overal
agreement
induc
sputum
np
sampl
patient
high
viral
pathogen
howev
nearli
one
third
control
without
respiratori
infect
least
one
viru
present
upperrespiratori
airway
suggest
presenc
viru
np
may
suffici
ascrib
etiolog
even
rsv
differ
viral
preval
case
control
statist
signific
p
although
number
rsv
detect
small
seven
virus
found
induc
sputum
suggest
induc
sputum
analysi
could
relev
viral
detect
case
cultur
goodqual
induc
sputum
yield
bacteria
differ
speci
pneumonia
h
influenza
catarrhali
note
bacteria
also
known
involv
nasopharyng
colon
healthi
children
children
upper
respiratori
tract
infect
confirm
studi
bacteri
colon
among
control
fact
bacteria
isol
induc
sputum
also
cultur
match
np
indic
exclud
possibl
contamin
upper
respiratori
secret
therefor
would
interest
determin
pathogen
isol
goodqual
induc
sputum
sampl
like
respons
respiratori
infect
absent
np
collect
simultan
order
progress
interpret
find
pair
sampl
induc
sputum
np
comparison
gold
standard
method
eg
transthorac
needl
aspir
need
altern
assess
differ
bacteri
load
site
may
help
distinguish
colon
infect
approach
plan
perch
studi
although
emphas
limit
pathogen
detect
ascrib
etiolog
diagnosi
find
may
nevertheless
reflect
true
predomin
virus
among
case
hospit
lri
set
good
primari
care
high
h
influenza
type
b
hib
pneumococc
vaccin
coverag
high
access
antibiot
pediatr
respiratori
ill
bacteri
origin
prevent
treat
outpati
set
never
requir
hospit
trial
hib
vaccin
lombok
indonesia
use
activ
surveil
identifi
sick
children
home
treat
villag
clinic
earli
cours
ill
vaccin
show
protect
effect
hospit
lri
suggest
earli
treatment
hib
case
prevent
progress
sever
diseas
similar
result
observ
protect
hospit
lri
pneumococc
conjug
vaccin
trial
among
nativ
american
k
obrien
person
commun
togeth
result
indic
virus
caus
major
sever
hospit
case
lri
locat
good
access
outpati
antibiot
treatment
support
etiolog
find
studi
relat
point
studi
also
like
differ
perch
studi
major
enrol
patient
diagnosi
bronchiol
rather
sever
pneumonia
perch
studi
enrol
hospit
case
sever
sever
pneumonia
defin
definit
nonspecif
like
captur
case
bronchiol
well
pneumonia
perch
studi
attempt
exclud
children
bronchiol
give
children
bronchodil
challeng
children
indrawn
lower
chest
wall
resolv
therapi
regardless
effect
wheez
consid
like
bronchiol
exclud
main
perch
studi
conclus
high
rate
viral
pathogen
detect
attribut
newli
develop
techniqu
eg
pcr
describ
elsewher
bacteri
detect
remain
challeng
induc
sputum
analysi
hamper
difficulti
obtain
good
qualiti
specimen
may
consequ
collect
method
studi
need
order
properli
distinguish
infect
colon
consist
compar
find
np
induc
sputum
refer
standard
pilot
studi
allow
us
improv
studi
design
multisit
perch
studi
follow
respect
emphas
import
good
induc
sputum
collect
techniqu
use
method
shown
yield
high
qualiti
specimen
ii
highlight
potenti
barrier
control
enrol
abbrevi
ni
inform
ci
confid
interv
result
given
pair
induc
sputum
specimen
nasopharyng
specimen
n
regardless
qualiti
induc
sputum
b
result
given
goodqual
induc
sputum
specimen
match
nasopharyng
specimen
n
